MedTrace Logo

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

NCT07029516 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-01-26

No results posted yet for this study

Summary

A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up

Conditions

  • Nail Psoriasis
  • Nail Damage
  • Mycosis

Interventions

OTHER

Cosmetic patch containing urea applicated daily for 3 months

Daily application of the patch on toes, 3 months treatment

OTHER

Placebo patch application

Daily application of a placebo patch on toes for a 3 months treatment

Sponsors & Collaborators

  • Nextrasearch S.r.l.s.

    collaborator OTHER

  • Wooshin Labottach Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07029516 on ClinicalTrials.gov